文献速递冠心病

手术相关与自发性心肌梗死后的死亡率比较

Mortality After Procedural or Spontaneous Myocardial Infarction.
PubMed 文献 · J Am Coll Cardiol · 2024-01-01

本研究纳入2012至2020年接受PCI的10707例患者,其中8515例为慢性冠脉综合征(CCS),2192例为自发性心肌梗死(spMI)。CCS患者中913例(10.7%)发生手术相关心肌梗死(pMI)。与无心肌梗死患者(1年死亡率1.4%)相比,肌钙蛋白峰值>35倍正常参考上限(URL)时,pMI和spMI的1年死亡率均显著升高,调整后风险比分别为4.40和7.57;而肌钙蛋白≤35倍URL时,仅spMI与死亡率增加相关。

要点

  • 肌钙蛋白峰值>35倍URL时,pMI和spMI均与1年死亡率显著增加独立相关。
  • 肌钙蛋白峰值≤35倍URL时,仅spMI与1年死亡率增加相关,pMI无显著影响。
  • pMI患者肌钙蛋白峰值多集中于>1-5倍和>5-35倍URL,而spMI患者多>35倍URL。

核心结论

  • 肌钙蛋白峰值>35倍URL时,pMI和spMI均显著增加1年全因死亡风险。
  • 肌钙蛋白峰值≤35倍URL时,仅spMI与1年死亡率增加相关,pMI无显著影响。

研究设计与样本

  • 回顾性队列研究,纳入2012至2020年接受PCI的10707例患者,其中CCS 8515例,spMI 2192例。
  • pMI定义为CCS患者PCI后肌钙蛋白升高>1倍URL;spMI定义为伴肌钙蛋白升高的急性冠脉综合征。
  • 以CCS患者PCI后肌钙蛋白≤1倍URL为参照组,按肌钙蛋白峰值分三层(>1-5倍、>5-35倍、>35倍URL)分析1年全因死亡风险。

主要发现

  • CCS患者中913例(10.7%)发生pMI。
  • pMI患者肌钙蛋白峰值>1-5倍、>5-35倍、>35倍URL的比例分别为53%、41%、6%;spMI患者分别为24%、38%、37%。
  • 肌钙蛋白峰值>35倍URL时,pMI组1年死亡率为7.7%(调整HR 4.40,95%CI 1.59-12.2),spMI组为8.5%(调整HR 7.57,95%CI 5.44-10.5),参照组为1.4%。
  • spMI患者肌钙蛋白峰值>1-5倍或>5-35倍URL时,1年死亡率亦增加。

临床怎么用

  • PCI术后应监测肌钙蛋白峰值,若>35倍URL需警惕1年死亡风险显著升高。
  • 对于pMI且肌钙蛋白峰值≤35倍URL的患者,其死亡风险与无MI者无显著差异,可避免过度干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It remains unclear whether procedural myocardial infarction (pMI) and spontaneous myocardial infarction (spMI) have a similar impact on prognosis. OBJECTIVES: The aim of this study was to assess mortality after pMI and spMI. METHODS: Patients with chronic coronary syndrome (CCS) and baseline troponin ≤1× the upper reference level (URL) or with acute spMI who underwent percutaneous coronary intervention (PCI) were included. PMI was defined as post-PCI troponin increase >1× URL in patients with CCS. SpMI comprised any acute coronary syndrome with elevated troponin. The 1-year risk of all-cause death was assessed after pMI and spMI across 3 strata of troponin elevation (>1-5×, >5-35×, and >35× URL), with CCS patients having post-PCI troponin ≤1× URL as a reference group. Conventional troponin I was measured using the Architect methodology (Abbott). RESULTS: Among 10,707 patients undergoing PCI from 2012 to 2020, 8,515 patients presented with CCS and 2,192 with spMI. Among CCS patients, 913 (10.7%) had pMI. Troponin peaks >1-5×, >5-35×, and >35× URL were observed in 53%, 41%, and 6% of patients with pMI, and in 24%, 38%, and 37% of patients with spMI, respectively. Mortality at 1 year was higher after pMI (7.7%; adjusted HR: 4.40; 95% CI: 1.59-12.2), and spMI (8.5%; adjusted HR: 7.57; 95% CI: 5.44-10.5) with troponin peak >35× URL compared with no-MI (1.4%). Mortality was also increased after spMI with troponin peak >1-5× or >5-35× URL. CONCLUSIONS: Mortality at 1 year was significantly increased after pMI and spMI with troponin peak >35× URL, whereas for troponin levels ≤35× only spMI had a relevant impact on mortality.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Spirito, Sartori, Koshy, et al. Mortality After Procedural or Spontaneous Myocardial Infarction. J Am Coll Cardiol. 2024. PMID: 39048279. doi:10.1016/j.jacc.2024.04.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。